User:ClueBot III/Master Detailed Indices/Talk:Molnupiravir
| Order | Header | Start Date | End Date | Comments | Size | Archive |
|---|---|---|---|---|---|---|
| 1 | Covid19 | 2020-12-06 06:48 | 2021-10-12 14:54 | 5 | 2166 | Talk:Molnupiravir/Archive 1 |
| 2 | IUPAC name | 2021-10-01 15:54 | 2021-10-02 21:36 | 2 | 603 | Talk:Molnupiravir/Archive 1 |
| 3 | Seasons | 2021-10-12 14:49 | 2021-10-12 14:49 | 1 | 775 | Talk:Molnupiravir/Archive 1 |
| 4 | "See also" section | 2021-10-04 12:06 | 2021-10-04 17:17 | 3 | 1154 | Talk:Molnupiravir/Archive 1 |
| 5 | Registry number | 2021-10-13 00:40 | 2021-10-13 11:12 | 2 | 979 | Talk:Molnupiravir/Archive 1 |
| 6 | Cancer and birth defects claims | 2021-10-15 19:12 | 2021-10-18 23:36 | 3 | 1306 | Talk:Molnupiravir/Archive 1 |
| 7 | Etymology of the name | 2021-11-04 13:24 | 2021-11-04 16:08 | 3 | 678 | Talk:Molnupiravir/Archive 1 |
| 8 | Marketing and expected sales | 2021-11-09 00:32 | 2021-11-09 07:10 | 2 | 1346 | Talk:Molnupiravir/Archive 1 |
| 9 | Concerns raised over mutation of SARS-CoV-2 | 2021-11-09 13:49 | 2022-01-05 14:19 | 25 | 24191 | Talk:Molnupiravir/Archive 1 |
| 10 | French Regulators Refuse Authorization and NIH recommends only use as a last resort | 2022-02-08 14:26 | 2022-02-08 14:26 | 1 | 5117 | Talk:Molnupiravir/Archive 1 |
| 11 | See also (for early covid-19 treatment): Pfizer Paxlovid. | 2021-11-14 21:58 | 2021-11-15 11:57 | 3 | 1126 | Talk:Molnupiravir/Archive 1 |
| 12 | Phase III results on NEJM: not WP:MEDRS? | 2021-12-27 15:12 | 2021-12-29 16:19 | 7 | 4796 | Talk:Molnupiravir/Archive 1 |